Literature DB >> 21508500

Facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T1- and T2-weighted magnetic resonance imaging.

Fengqin Hu1, Qiaojuan Jia, Yilin Li, Mingyuan Gao.   

Abstract

The development of new types of high-performance nanoparticulate MR contrast agents with either positive (T(1)) or dual-contrast (both positive and negative, T(1) + T(2)) ability is of great importance. Here we report a facile synthesis of ultrasmall PEGylated iron oxide nanoparticles for dual-contrast T(1)- and T(2)-weighted MRI. The produced superparamagnetic iron oxide nanoparticles (SPIONs) are of high crystallinity and size uniformity with an average diameter of 5.4 nm, and can be individually dispersed in the physiological buffer with high stability. The SPIONs reveal an impressive saturation magnetization of 94 emu g(-1) Fe(3)O(4), the highest r(1) of 19.7 mM(-1) s(-1) and the lowest r(2)/r(1) ratio of 2.0 at 1.5 T reported so far for PEGylated iron oxide nanoparticles. T(1)- and T(2)-weighted MR images showed that the SPIONs could not only improve surrounding water proton signals in the T(1)-weighted image, but induce significant signal reduction in the T(2)-weighted image. The good contrast effect of the SPIONs as T(1) + T(2) dual-contrast agents might be due to its high magnetization, optimal nanoparticle size for T(1) + T(2) dual-contrast agents, high size monodispersity and excellent colloidal stability. In vitro cell experiments showed that the SPIONs have little effect on HeLa cell viability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508500     DOI: 10.1088/0957-4484/22/24/245604

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  14 in total

Review 1.  Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications.

Authors:  Seyed Mohammadali Dadfar; Karolin Roemhild; Natascha I Drude; Saskia von Stillfried; Ruth Knüchel; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2019-01-11       Impact factor: 15.470

2.  Magnetic barcode imaging for contrast agents.

Authors:  Andy H Hung; Laura M Lilley; Fengqin Hu; Victoria S R Harrison; Thomas J Meade
Journal:  Magn Reson Med       Date:  2016-04-08       Impact factor: 4.668

Review 3.  Iron Oxide Nanoparticles as T1 Contrast Agents for Magnetic Resonance Imaging: Fundamentals, Challenges, Applications, and Prospectives.

Authors:  Mike Jeon; Mackenzie V Halbert; Zachary R Stephen; Miqin Zhang
Journal:  Adv Mater       Date:  2020-06-04       Impact factor: 32.086

Review 4.  Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging.

Authors:  Juan Pellico; Jordi Llop; Irene Fernández-Barahona; Riju Bhavesh; Jesús Ruiz-Cabello; Fernando Herranz
Journal:  Contrast Media Mol Imaging       Date:  2017-11-21       Impact factor: 3.161

5.  Synthesis and In Vitro Characterization of Fe3+-Doped Layered Double Hydroxide Nanorings as a Potential Imageable Drug Delivery System.

Authors:  Lijun Wang; Yusen Wang; Xiaoxia Wang
Journal:  Materials (Basel)       Date:  2017-09-27       Impact factor: 3.623

6.  Enhanced MRI T 2 Relaxivity in Contrast-Probed Anchor-Free PEGylated Iron Oxide Nanoparticles.

Authors:  Bibek Thapa; Daysi Diaz-Diestra; Juan Beltran-Huarac; Brad R Weiner; Gerardo Morell
Journal:  Nanoscale Res Lett       Date:  2017-04-27       Impact factor: 4.703

Review 7.  Recent advances in engineering iron oxide nanoparticles for effective magnetic resonance imaging.

Authors:  Zhenghuan Zhao; Muyao Li; Jie Zeng; Linlin Huo; Kun Liu; Ruixue Wei; Kaiyuan Ni; Jinhao Gao
Journal:  Bioact Mater       Date:  2021-10-19

Review 8.  Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents.

Authors:  Derong Zhu; Fuyao Liu; Lina Ma; Dianjun Liu; Zhenxin Wang
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

9.  Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging.

Authors:  Lydia Sandiford; Alkystis Phinikaridou; Andrea Protti; Levente K Meszaros; Xianjin Cui; Yong Yan; George Frodsham; Peter A Williamson; Nicholas Gaddum; René M Botnar; Philip J Blower; Mark A Green; Rafael T M de Rosales
Journal:  ACS Nano       Date:  2012-12-10       Impact factor: 15.881

10.  Targeting T1 and T2 dual modality enhanced magnetic resonance imaging of tumor vascular endothelial cells based on peptides-conjugated manganese ferrite nanomicelles.

Authors:  Mingfu Gong; Hua Yang; Song Zhang; Yan Yang; Dong Zhang; Zhaohui Li; Liguang Zou
Journal:  Int J Nanomedicine       Date:  2016-08-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.